{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T18:10:34Z","timestamp":1648836634151},"reference-count":7,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0378-6323.60554","type":"journal-article","created":{"date-parts":[[2010,4,10]],"date-time":"2010-04-10T06:21:48Z","timestamp":1270880508000},"page":"182","source":"Crossref","is-referenced-by-count":0,"title":["Pulse therapy - Credibility of evidence"],"prefix":"10.25259","volume":"76","author":[{"given":"AmrinderJ","family":"Kanwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipankar","family":"De","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.60554-1","first-page":"75;83","volume-title":"Pulse therapy for pemphigus: The burden of proof","author":"Singh","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"http:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.60554-2","first-page":"217","volume-title":"Current regimen of pulse therapy for pemphigus: Minor modifications, improved results","author":"Pasricha","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"http:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.60554-3","first-page":"200","volume-title":"Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study","author":"Rose","year":"2005","journal-title":"J Dtsch Dermatol Ges"},{"key":"key-10.4103\/0378-6323.60554-4","first-page":"85","volume-title":"Prolonged antimicrobial and oral cyclophosphamide therapy in pemphigus: need for caution","author":"Ramam","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"http:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0378-6323.60554-5","first-page":"25","volume-title":"Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris","author":"Werth","year":"2008","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.60554-6","first-page":"73","volume-title":"Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus","author":"Pasricha","year":"1988","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.60554-7","first-page":"228","volume-title":"Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus","author":"Kanwar","year":"2002","journal-title":"Dermatology"}],"container-title":["Indian Journal of Dermatology, Venereology, and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T00:44:53Z","timestamp":1612658693000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/pulse-therapy-credibility-of-evidence\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"alternative-id":["60554"],"URL":"https:\/\/doi.org\/10.4103\/0378-6323.60554","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}